US childhood vaccination rates for MMR are dropping below the critical 95% threshold, risking increased measles outbreaks and prompting public health officials to enhance collaboration with pharmacists to safeguard children’s health.
Pediatricians are warning that falling measles, mumps and rubella vaccination rates are leaving more children vulnerable, and that the problem is no longer abstract. The latest federal school vaccination data show MMR coverage among US kindergartners dropped to 92.4% in the 2025-26 school year, further below the 95% level generally needed to help block outbreaks, while some communities remain far lower. The CDC says that patchwork coverage, combined with rising global measles activity, increases the chance that the virus will keep finding susceptible pockets.
Molly O’Shea, a paediatrician in Bloomfield Hills, Michigan, told Drug Topics that the decline is already shaping children’s lives in practical ways. She said more than 300,000 children are expected to enter kindergarten without MMR protection compared with the previous year, a shortfall she described as likely to mean missed school, sport and other normal childhood activities if those children later catch measles. Her comments reflect a wider concern among clinicians that the damage from lower uptake is not only statistical, but personal and disruptive for families.
The health risks are severe. The CDC says measles spreads easily through the air and can linger in a room for up to two hours after an infected person leaves. Typical symptoms begin with fever, cough, a runny nose and red eyes, followed by the rash; complications can include diarrhoea, ear infections, pneumonia and, in rare cases, a fatal brain disorder that may appear years later. The American Academy of Pediatrics also notes that two-dose MMR protection starts in infancy and is routinely given before school age, underscoring why missed doses matter.
The consequences are increasingly measurable in dollars as well as in illness. A study in Proceedings of the National Academy of Sciences estimated that measles cost the United States $244.2 million in 2025 and projected costs of $7.77 billion over five years if vaccination rates keep falling. Public health officials and paediatric groups are therefore pressing for closer co-operation between paediatricians and pharmacists, who often see families more frequently and can reinforce vaccination messages, answer questions and direct children back to routine care.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
